On-Demand Webinar

Formulate Faster: A Purpose-Built Toolkit for Bioequivalence (Phoenix IVIVC Toolkit)

This webinar introduces the Phoenix IVIVC Toolkit, showing how to perform BE analysis and build…

CertaraFebruary 27, 2026

Conference

Marbach DDI Workshop 2026

CertaraFebruary 26, 2026

Blog

Rare disease day 2026: Accelerating rare disease drug development through cross-functional innovation

On Rare Disease Day 2026, Certara experts share how cross-functional innovation, regulatory strategies for rare…

CertaraFebruary 26, 2026

Blog

From documentation to design: Building a scalable metadata strategy for clinical research

Learn how clinical teams are treating metadata as infrastructure to improve reuse, auditability, and standards…

Trevor MankusFebruary 26, 2026

On-Demand Webinar

Metatdata as Infrastructure: Designing for Reuse, Insight, and Auditability

Watch this on-demand webinar to learn how leading clinical teams design scalable metadata strategies that…

CertaraFebruary 26, 2026

Press Release

Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance

FY 2025 Revenue of $418.8M (9% growth) and Adj. EBITDA of $134.5M (10% growth) Fourth…

CertaraFebruary 26, 2026

Publication

Pharmacokinetics, Safety Profile, and Tolerability of MN-08 Tablets after Single and Multiple Ascending Doses in Healthy Chinese Volunteers

Find out how Phase I study shows dose-related MN-08 exposure, 21–32 h half-life, and good…

CertaraFebruary 25, 2026

Guide

A Practical Guide to Sales Enablement in Pharma and Life Sciences

Evidence-led strategies for sales enablement in Life Sciences, Pharma, and MedTech. Influence payers & decision…

Christian PichardoFebruary 24, 2026

Live Events

Certara Biotech Forum: Workshop on Developing Investor-Ready Strategies

–

Diana Marcantonio, PhDFebruary 24, 2026

Webinar

Maximizing the Impact of Antibody–Drug Conjugates (ADCs): Model-Informed Labeling, Expansion, and Market Access

Danielle PillsburyFebruary 23, 2026

Formulate Faster: A Purpose-Built Toolkit for Bioequivalence (Phoenix IVIVC Toolkit)

Marbach DDI Workshop 2026

Rare disease day 2026: Accelerating rare disease drug development through cross-functional innovation

From documentation to design: Building a scalable metadata strategy for clinical research

Metatdata as Infrastructure: Designing for Reuse, Insight, and Auditability

Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance

Pharmacokinetics, Safety Profile, and Tolerability of MN-08 Tablets after Single and Multiple Ascending Doses in Healthy Chinese Volunteers

A Practical Guide to Sales Enablement in Pharma and Life Sciences

Certara Biotech Forum: Workshop on Developing Investor-Ready Strategies

Maximizing the Impact of Antibody–Drug Conjugates (ADCs): Model-Informed Labeling, Expansion, and Market Access

Newsletter sign up

Quick links

Solutions

Contact